Literature DB >> 14675785

Newly identified exons encoding novel variants of p94/calpain 3 are expressed ubiquitously and overlap the alpha-glucosidase C gene.

Yukiko Kawabata1, Shoji Hata, Yasuko Ono, Yoshimasa Ito, Koichi Suzuki, Keiko Abe, Hiroyuki Sorimachi.   

Abstract

There are two classes of an intracellular 'modulator protease', calpain: ubiquitous and tissue-specific. p94/calpain 3 is an example of the latter, predominantly expressed in muscle. A defect in the p94 gene causes muscular dystrophy. Here we report that human and mouse p94 genes have a possible novel alternative promoter expressing p94 variants in all tissues examined including human lens epithelial cells. The possible promoter region and the following novel exons overlap the 3' region of the neutral alpha-glucosidase C gene. Unlike p94, the novel p94 variants expressed in COS7 cells do not undergo rapid autolysis, suggesting basic functions different from p94.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14675785     DOI: 10.1016/s0014-5793(03)01324-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

1.  Possible functions of p94 in connectin-mediated signaling pathways in skeletal muscle cells.

Authors:  Koichi Ojima; Yasuko Ono; Shoji Hata; Suguru Koyama; Naoko Doi; Hiroyuki Sorimachi
Journal:  J Muscle Res Cell Motil       Date:  2005       Impact factor: 2.698

2.  Characterization of novel CAPN3 isoforms in white blood cells: an alternative approach for limb-girdle muscular dystrophy 2A diagnosis.

Authors:  L Blázquez; M Azpitarte; A Sáenz; M Goicoechea; D Otaegui; X Ferrer; I Illa; E Gutierrez-Rivas; J J Vilchez; A López de Munain
Journal:  Neurogenetics       Date:  2008-06-19       Impact factor: 2.660

3.  Calpain3 is expressed in a proteolitically active form in papillomavirus-associated urothelial tumors of the urinary bladder in cattle.

Authors:  Sante Roperto; Roberta De Tullio; Cinzia Raso; Roberto Stifanese; Valeria Russo; Marco Gaspari; Giuseppe Borzacchiello; Monica Averna; Orlando Paciello; Gianni Cuda; Franco Roperto
Journal:  PLoS One       Date:  2010-04-22       Impact factor: 3.240

Review 4.  Calpain 3, the "gatekeeper" of proper sarcomere assembly, turnover and maintenance.

Authors:  Jacques S Beckmann; Melissa Spencer
Journal:  Neuromuscul Disord       Date:  2008-10-29       Impact factor: 4.296

5.  Age-related cataracts in alpha3Cx46-knockout mice are dependent on a calpain 3 isoform.

Authors:  Yajun Tang; Xiangyang Liu; Rebecca K Zoltoski; Layne A Novak; R Antonio Herrera; Isabelle Richard; Jer R Kuszak; Nalin M Kumar
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-06       Impact factor: 4.799

6.  Comprehensive survey of p94/calpain 3 substrates by comparative proteomics--possible regulation of protein synthesis by p94.

Authors:  Yasuko Ono; Chikako Hayashi; Naoko Doi; Fujiko Kitamura; Mayumi Shindo; Kenichi Kudo; Takuichi Tsubata; Mitsuaki Yanagida; Hiroyuki Sorimachi
Journal:  Biotechnol J       Date:  2007-05       Impact factor: 4.677

7.  Transcriptional and translational effects of intronic CAPN3 gene mutations.

Authors:  Anna Chiara Nascimbeni; Marina Fanin; Elisabetta Tasca; Corrado Angelini
Journal:  Hum Mutat       Date:  2010-09       Impact factor: 4.878

Review 8.  Calpain chronicle--an enzyme family under multidisciplinary characterization.

Authors:  Hiroyuki Sorimachi; Shoji Hata; Yasuko Ono
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2011       Impact factor: 3.493

9.  Calpain-3 impairs cell proliferation and stimulates oxidative stress-mediated cell death in melanoma cells.

Authors:  Daniele Moretti; Barbara Del Bello; Giulia Allavena; Alessandro Corti; Cinzia Signorini; Emilia Maellaro
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

10.  Regulatory effect of chrysin on expression of lenticular calcium transporters, calpains, and apoptotic-cascade components in selenite-induced cataract.

Authors:  Mahalingam Sundararajan; Philip A Thomas; P Archana Teresa; Muniyandi Anbukkarasi; Pitchairaj Geraldine
Journal:  Mol Vis       Date:  2016-04-30       Impact factor: 2.367

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.